All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Autoimmunity and Limitations of Cancer Vaccines
Aug 20, 2014
targetedonc.com
BPDCN: Epidemiology, Pathophysiology, and Diagnosis
Sep 27, 2022
targetedonc.com
Managing R/R Multiple Myeloma: Current Strategies and Future Dir
…
2 weeks ago
targetedonc.com
An Introduction to Front-line Nivolumab/Ipilimumab Therapy fo
…
1 month ago
targetedonc.com
Nirogacestat Shows Statistically Significant Improvements in Des
…
Nov 28, 2023
targetedonc.com
Future Perspectives on the Relapsed/Refractory Follicular Ly
…
1 month ago
targetedonc.com
BCL-2 Inhibitors in AML: Treatment Considerations
Dec 23, 2019
targetedonc.com
Key Updates from ARMANI in Advanced HER2- Gastric/GEJ Can
…
8 months ago
targetedonc.com
SABCS 2020 Updates: ExteNET and CONTROL Trials
Jan 29, 2021
targetedonc.com
Overview of phase 3 EMERALD study of elacestrant for ER , HER
…
3 months ago
targetedonc.com
5:30
EMERALD Subgroup Analysis in HER2-Low Metastatic Breast Canc
…
Dec 8, 2023
targetedonc.com
Scenario 2: Ibrutinib and Ruxolitinib as Treatment Options in cGVHD
Apr 4, 2022
targetedonc.com
The Targeted Pulse: Tune-In to Discover The Most Recent FDA A
…
2 months ago
targetedonc.com
Upcoming Insights – Strategies for Management of Dermatological R
…
1 month ago
targetedonc.com
Targeted Therapies and Immunotherapy Play Greater Rol
…
Feb 27, 2023
targetedonc.com
An Overview of BCG-Unresponsive Non-Muscle-Invasive Bladder Can
…
Nov 30, 2023
targetedonc.com
Perspectives: PEACE-3 in Context of Current Landscape
4 days ago
targetedonc.com
BrECADD Shows Promise as New Standard for Advanced Hodgkin L
…
8 months ago
targetedonc.com
INAVO120: Inavolisib Combination Therapy in PIK3CA-Mutated Breas
…
8 months ago
targetedonc.com
Overview of the STARTER-NET Study
1 week ago
targetedonc.com
An Academic Perspective to First-Line Treatment Decisions for EGF
…
1 week ago
targetedonc.com
Phase 3 NATALEE Study Assesses Ribociclib Plus ET in Early Breast
…
Jul 1, 2023
targetedonc.com
Unmet Needs Persist for Patients with Melanoma
7 months ago
targetedonc.com
Overview of Graft-Versus-Host Disease
5 months ago
targetedonc.com
ESMO 2024: Updates in NIAGARA Study
4 months ago
targetedonc.com
ASH 2024 Preview for Community Oncologists: The Show and After
…
2 months ago
targetedonc.com
Advancements in AML Treatment in the Past 10 Years
6 months ago
targetedonc.com
Reviewing the Options for Bladder Cancer in Different Settings
1 month ago
targetedonc.com
TRANSCEND 004: Highlights from ASH 2024
1 month ago
targetedonc.com
Frontline Therapy for R/R DLBCL: TAFA/LEN/R-CHOP
Nov 24, 2021
targetedonc.com
See more videos
More like this
Feedback
Feedback